Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 30, 2015 2:19 AM ET

Capital Markets

Company Overview of Pasteur Institute

Company Overview

25-28 Rue Doctor Droux



Key Executives for Pasteur Institute

Vice President and Head of Applications
Age: 65
Compensation as of Fiscal Year 2015.

Pasteur Institute Key Developments

The Institut Carnot Curie Cancer Presents at BIO-Europe Spring 2015, Mar-10-2015 10:00 AM

The Institut Carnot Curie Cancer Presents at BIO-Europe Spring 2015, Mar-10-2015 10:00 AM. Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.

Moderna Therapeutics Enters into Research Collaboration with Institut Pasteur

Moderna Therapeutics has entered into a long-term strategic research collaboration with Institut Pasteur. The contract has been signed to discover and develop drugs and vaccines using its mRNA Therapeutics platform. It will be managed by its venture company, Valera, which is focused on the advancement of vaccines and therapeutics for the prevention and treatment of viral, bacterial and parasitic infectious diseases. Under the deal, Valera will sponsor programmes of preclinical and clinical research at the Institut Pasteur, aimed at discovering and developing new approaches to combat known and emerging viral and bacterial diseases.

Myriad RBM Joins Institut Pasteur in the Global Fight against Tuberculosis

Myriad RBM announced that it will assist the Institut Pasteur in a public-private research collaboration to fight the global tuberculosis (TB) epidemic. This research project is funded by the Bill & Melinda Gates Foundation through a grant to the Institut Pasteur. The proof-of-concept study will evaluate patients with latent and active TB infections who are affiliated with the South African Tuberculosis Vaccine Initiative (SATVI) clinical study sites. The goals of this study are to field-test Myriad RBM's TruCulture® system as a point-of-care blood collection and immune response monitoring method and to stratify patients with active and latent tuberculosis. Myriad RBM will supply the study with its revolutionary TruCulture collection systems. Once the blood samples are collected, Myriad RBM and the Institut Pasteur will seek to discover protein biomarkers important in regulating the immune system response using Myriad RBM's proprietary MAP (Multi-Analyte Profiling) platform.

Similar Private Companies By Industry

Company Name Region
Tradingplaces SAS Europe
Groupe Carmin Europe
Développement & Finance Europe
WARF Europe
CA Indosuez Private Banking Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Pasteur Institute, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at